| 08:30 |
Welcome Comprehensive Cancer Center Zurich
Markus G. Manz, Chair CCCZWelcome 7th Zurich Precision Oncology Symposium
Markus Rudin, Director The LOOP Zurich |
|
Session 1: Diagnostics / Technologies – Bernd Bodenmiller & Jana Pachlopnik |
| 08:40 |
Personalized drug screening for precision oncology
Berend Snijder, Dr., Faculty at the Botnar Institute of Immune Engineering |
| 09:10 |
Precision oncology in the age of agentic AI
Daniel Truhn, Univ.-Prof. Dr. med., RWTH Aachen, Germany |
| 09:40 |
Precise, fast, accessible: Neuropathology 3.0
Felix Sahm, Prof. Dr. Dr. med., University Hospital Heidelberg, Germany |
| 10:10 |
Coffee Break |
|
Session 2: Translational & Clinical Research – Solid Tumors
Andreas Wicki & Anne Müller |
| 10:40 |
Innovative trial design and infrastructure for precision oncology
Benjamin Kasenda, PD Dr., University Hospital Basel |
| 11:10 |
Predictive Biomarkers for Immunotherapy Response: From Translational Research to Clinical Practice
Ruben Bill, Dr. med. et phil. nat., Inselspital Bern |
| 11:40 |
Virtual Patient Labs: AI-Driven Simulation and Diagnostics for Precision Oncology
Charlotte Bunne, Prof. Dr., EPFL Lausanne |
| 12:00 |
Poster Pitch Session |
| 12:30 |
Mittagspause und Poster |
|
Session 3: Translational & Clinical Research – Hemato. Malignancies
Jean-Pierre Bourquin & Thorsten Zenz |
| 13:30 |
Molecular Glue Degraders
Nicolas Thomä, Prof., EPFL Lausanne |
| 14:00 |
Data-driven hallmarks for AML
Olli Kallioniemi, Prof., Research Director, Institute for Molecular Medicine Finland (FIMM) and Professor of Molecular Precision Medicine, SciLifeLab and Karolinska Insitute |
| 14:30 |
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies
Sascha Dietrich, Univ.-Prof. Dr. med., University Hospital Düsseldorf, Germany |
| 15:00 |
Cell surface protein degraders (SureTACs) for precision oncology
Prof. Dr. Madelon Maurice, University Medical Center Utrecht, The Netherlands |
| 15:30 |
Coffee Break |
|
Session 4: Data Science – Markus Rudin & Virginie Uhlmann
In cooperation with MOH & CCCZ Grand Rounds |
| 16:00 |
AI Tumor Board
Michael Krauthammer, Prof. Dr. med., University Hospital Zurich |
| 16:30 |
Multimodal AI for precision pathology
Frederick Klauschen, Prof., Institute of Pathology, LMU Munich, Germany |
| 17:00 |
Predictive modelling of drug combination responses
Tero Aittokallio, PhD, Prof., Oslo University Hospital, Norway |
| 17:30 |
Wrap-up
Thorsten Zenz, Prof. Dr. med., University Hospital Zurich |
